Hygea Medical Technology Co., Ltd., founded in 2010, is headquartered in Haidian District, Beijing, China. As a National High-tech Enterprise integrating R&D, production, sales and marketing, the company focuses on Interventional Oncology fields of "percutaneous intervention" and "transvascular intervention".
The first released product, "Co-Ablation System", is leading the industry with the cutting-edge technology, the product introduces the first combined ablation system in the world by integrating cryoablation and hyperthermia ablation in one system. In 2020, Co-Ablation System obtained the CE Marking Certificate and started product marketing in European countries. The Co-Ablation System AI Epic series has won the iF DESIGN AWARD 2020.
The company has set up Beijing Key Laboratory of Cryogenic Biomedical Engineering and Post-Doctoral Research Center. As to patents, the company obtains more than 150 patents both in China and abroad. Hygea Medical Technology Co., Ltd. was granted awards of the William Begell Medal, National Specialized and New "Little Giant" Enterprise, First Prize of Beijing Science and Technology Award, etc.
We are committed to creating a minimally invasive treatment platform-type enterprise.
Chinese and international patents
Number of cumulative Top hospitals installed
Number of cumulative patients treated
Minimally invasive oncology is an active topic in international frontier medicine, and "MADE IN CHINA" has become a key member of the global toolbox.
From August 6th to August 11th, 2022, hosted by Chinese Medical Association Beijing Branch Secretariat, Beijing Medical Association Respiratory Endoscopy and Interventional Branch, “ The 9th Beijing Respiratory Endoscopy and Interventional Respiratory Medicine Summit Forum, The 7th Beijing-Tianjin-Hebei Interventional Pulmonology Symposium and the 16th Peking University International Interventional Pulmonology Technical Training Course” were held in Beijing. The national experts in the field of interventional pulmonology gathered to share new progress, new theories, new technologies and new application in the field.
There is such a company. The founder of the company, Huang Qianfu, and his team have spent more than ten years grinding "a probe"-Co-Ablation System, a cryosurgery system for minimally invasive tumor treatment.